Press Releases

Washington DC. March 6, 2012. Yesterday, Senator Charles Grassley and Representative Darrell Issa released a letter asking the Obama Administration for assistance in assessing the e-mail monitoring policies of all federal agencies. This letter was sent in light of Congressional and Office of Special Counsel investigations into the Food and Drug Administration’s (FDA) illegal targeting of […]

SOX whistleblower protection covers mutual fund industry Washington, D.C. March 4, 2014. The U.S. Supreme Court ruled today in Lawson v. FMR, LLC that contractors and subcontractors of publicly traded companies are fully protected under the Sarbanes-Oxley Act for corporate whistleblowers. Significantly, in today’s decision the Supreme Court explicitly held that investment advisors and other “independent contractors” […]

Washington DC. February 15, 2012. Today, the Office of Special Council (OSC) opened a major investigation into the FDA’s targeted monitoring of employees who blew the whistle on defective medical devices. For the first time, the investigation into government monitoring of employees has been expanded beyond just the FDA. The OSC is evaluating new allegations of retaliatory surveillance […]

Representative Issa Calls FDA Purpose “Unlawful” Washington DC. February 10, 2012. Representative Darrell Issa, Chairman of the House Oversight and Government Reform Committee, launched an investigation into the FDA’s targeting of whistleblowers for highly intrusive monitoring and computerized searches. In a letter to FDA Commissioner Margaret Hamburg, Representative Issa said that interfering with an “employee’s right to provide […]